MD2377F1 - Method of treatment of puerperal endometritis - Google Patents

Method of treatment of puerperal endometritis Download PDF

Info

Publication number
MD2377F1
MD2377F1 MD20030231A MD20030231A MD2377F1 MD 2377 F1 MD2377 F1 MD 2377F1 MD 20030231 A MD20030231 A MD 20030231A MD 20030231 A MD20030231 A MD 20030231A MD 2377 F1 MD2377 F1 MD 2377F1
Authority
MD
Moldova
Prior art keywords
day
puerperal
treatment
solution
endometritis
Prior art date
Application number
MD20030231A
Other languages
Romanian (ro)
Other versions
MD2377G2 (en
Inventor
Dorina Muntean
Ludmila Etco
Iurie Roscin
Stefan Gatcan
Natalia Zarbailov
Natalia Alekseeva
Original Assignee
Inst Cercetari Stiintifice
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Cercetari Stiintifice, Univ Nicolae Testemitanu filed Critical Inst Cercetari Stiintifice
Priority to MDA20030231A priority Critical patent/MD2377G2/en
Publication of MD2377F1 publication Critical patent/MD2377F1/en
Publication of MD2377G2 publication Critical patent/MD2377G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to obstetrics and is meant for treatment of puerperal endometritis to confined women of increased infectious risk Summary of the invention consists in that on the 2-nd and the 3-rd day of the puerperal period it is carried out during 10...15 min once a day the lavage of the uterine cavity with sodium hypochloride solution in concentration of 600...700 mol/l and supplementary from the first day of the puerperal period it is administered 1,0 ml of 0,005% immunofan solution, intramuscular once a day during 5...10 days. Claims: 1
MDA20030231A 2003-09-18 2003-09-18 Method of treatment of puerperal endometritis MD2377G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030231A MD2377G2 (en) 2003-09-18 2003-09-18 Method of treatment of puerperal endometritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030231A MD2377G2 (en) 2003-09-18 2003-09-18 Method of treatment of puerperal endometritis

Publications (2)

Publication Number Publication Date
MD2377F1 true MD2377F1 (en) 2004-02-29
MD2377G2 MD2377G2 (en) 2004-08-31

Family

ID=32065055

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030231A MD2377G2 (en) 2003-09-18 2003-09-18 Method of treatment of puerperal endometritis

Country Status (1)

Country Link
MD (1) MD2377G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453274C1 (en) * 2010-10-15 2012-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО "КубГМУ") Method of selecting tactics of treating puerperas with post-natal purulent-septic diseases
RU2634471C2 (en) * 2015-12-31 2017-10-30 Общество с ограниченной ответственностью "ФОТЕК" Method for local treatment of postpartum endometritis

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3499G2 (en) * 2007-10-12 2008-09-30 Общественное Медико-Санитарное Учреждение Онкологический Институт Method of differentiated treatment of endometrial cancer
RU2646496C1 (en) * 2017-01-10 2018-03-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Омский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ОмГМУ Минздрава России) Method for post-delivery endometritis treatment using intrauterine introduction of formed vniitu-1 pvp sorbent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD186C2 (en) * 1994-03-01 1995-09-30 Etco Ludmila Method of endometritis treatment after cesarean section

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453274C1 (en) * 2010-10-15 2012-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО "КубГМУ") Method of selecting tactics of treating puerperas with post-natal purulent-septic diseases
RU2634471C2 (en) * 2015-12-31 2017-10-30 Общество с ограниченной ответственностью "ФОТЕК" Method for local treatment of postpartum endometritis

Also Published As

Publication number Publication date
MD2377G2 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
PT1782825E (en) Treatment of glycogen storage diseases type ii
MXPA04005865A (en) Pulmonary delivery of aminoglycosides.
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
DK1317419T3 (en) Cyanophenoxycarboxylic acid compounds and compositions to deliver active agents
TW200510343A (en) Substituted dihydroquinazolines
GB2368525A (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
ATE412412T1 (en) DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1-PYRAZOLE AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONAL DISEASES, SUCH AS PROSTATE OR MATERNAL CANCER
ATE545407T1 (en) PHARMACEUTICAL FORMULATION OF APOMORPHINE FOR BUCCAL ADMINISTRATION
UA72927C2 (en) Docetaxel-containing composition for treating hepatocellular carcinoma
MD2377F1 (en) Method of treatment of puerperal endometritis
AP1896A (en) The method of treating cancer
WO2005002617A3 (en) Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases
PL357999A1 (en) Lhrh-antagonists, production and use thereof as medicament
MD2444F1 (en) Method of prophylaxis of the puersperal endometritis
WO2003032909A3 (en) Methods of treating skin with diphosphonate derivatives
WO2003024486A1 (en) Remedies for bone loss
GB0028245D0 (en) New therapeutic use
MD2323F1 (en) Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma
MX2024013108A (en) Pharmaceutical composition suitable for vaginal administration in the form of ovules and use thereof
MX2020011523A (en) Pharmaceutical composition suitable for vaginal administration in the form of ovules and use thereof.
MD1715F1 (en) Method of prophylaxis and treatment of the precocious hypogalactia
MD2551G2 (en) Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MD2230F1 (en) Sulphuric ointment
MD1919F2 (en) Medicinal remedy

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees